# Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

> **NCT04867252** · PHASE2 · COMPLETED · sponsor: **Khyber Medical University Peshawar** · enrollment: 88 (actual)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** Resveratrol (1000mg twice a day), Myoinositol 1000mg (Twice a day)
- **DRUG:** Metformin (500 mg Twice a day), Pioglitazone (15 mg Twice a day)

## Key facts

- **NCT ID:** NCT04867252
- **Lead sponsor:** Khyber Medical University Peshawar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2021-08-03
- **Final completion:** 2021-08-03
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867252, "Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04867252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*